Karyopharm Therapeutics Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Boston, MA USA
Total Funding:$178.3M
Industry:Pharma
Founded:2008
Lead Investor(s):BofA Merrill Lynch, J.P. Morgan Securities LLC

Industry Ranking

Estimated Revenue & Financials

  • Karyopharm Therapeutics's estimated annual revenue is currently $30.3M per year.
  • Karyopharm Therapeutics received $Undisclosed in venture funding in January 2015.
  • Karyopharm Therapeutics's estimated revenue per employee is $78,795
  • Karyopharm Therapeutics's total funding is $178.3M.

Employee Data

  • Karyopharm Therapeutics has 385 Employees.
  • Karyopharm Therapeutics grew their employee count by 50% last year.
  • Karyopharm Therapeutics currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingPricing
Ironwood Pharma...
N/A445N/AN/AN/A
Infinity Pharma...
N/A411N/AN/AN/A
Karyopharm Ther...
$30.3M38550%N/AN/A
Carna Bioscienc...
$5.4M27N/AN/AN/A
Boston Pharmace...
$17.3M8648%N/AN/A
Vita Data Scien...
$10.3M5150%N/AN/A
Veristat
$51.9M25815%N/AN/A
Radius Health
N/A453N/AN/AN/A
Sunovion Pharma...
$546.3M2718N/AN/AN/A
Ariad Pharmaceu...
N/A179N/AN/AN/A
Missing a competitor? Contribute!?
Submit

Karyopharm Therapeutics Inc. is a clinical-stage pharmaceutical company focused on discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. For more information, please visit www.karyopharm.com

keywords:Biotechnology,Cleantech,Healthcare,Marketing,Pharmaceuticals,Wind Power

385

Number of Employees

$30.3M

Revenue (est)

1

Current Jobs

50%

Employee Growth %

$178.3M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Executive Contacts

NameTitleEmail
Amnon EylathAssociate Vice President & Quality Head
Borah KaabungaManager, Site Payments
Michael MasonChief Financial Officer
Sharon ShachamFounderEmail Available
Brian AustadSenior Vice President And Head Of Pharmaceutical SciencesEmail Available
Shijie TangExecutive Director, Head Of BiostatisticsEmail Available
Jatin ShahSvp Clinical Development
Sharon TamirDirector, Strategic Product Development, Head of Neurodegenerative and Infectious DiseasesEmail Available
William SenapedisDirectorEmail Available
Wen ChenSenior Director Of Pharmaceutical Sciences, Formulation DevelopmentEmail Available

Karyopharm Therapeutics News

12-Sep-19 - ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Karyopharm Therapeutics Inc. Investors of ...

NEW YORK, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds Karyopharm Therapeutics Inc.

12-Sep-19 - Karyopharm Announces XPOVIO™ (Selinexor) Presentations at the 17th International Myeloma ...

13, 2019 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (KPTI), an oncology-focused pharmaceutical company, today announced that ...

07-Sep-19 - Is Karyopharm Therapeutics Inc.'s (NASDAQ:KPTI) CEO Salary Justified?

Michael Kauffman became the CEO of Karyopharm Therapeutics Inc. (NASDAQ:KPTI) in 2011. This analysis aims first to contrast CEO ...

Karyopharm Therapeutics Funding

DateAmountRoundLead InvestorsReference
2011-11-03$10.0MA2Chione LtdArticle
2013-05-14$20.5MUndisclosedArticle
2013-05-21$48.2MBDelphi VenturesArticle
2013-08-02$19.0MBArticle
2015-01-07$UndisclosedUndisclosedBofA Merrill LynchArticle

Karyopharm Therapeutics Executive Hires

DateNameTitleReference
2014-04-11Christopher B. PrimianoVP General Counsel/SecretaryArticle
2014-08-11Justin RenzEVP/CFOArticle
2016-09-13Humphrey A.R. GardnerSVP Clinical DevelopmentArticle
2017-09-13Michael Falveyevp/Chief Financial Officer/TreasurerArticle
2018-06-26Anand VaradanEVP Chief Commercial OfficerArticle